Metagenomi Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-10
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $257.00K.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$748.00K.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was -$7.37M.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was -$3.05M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month |
|---|---|---|
| 2026-06-30 | $257.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$491.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$748.00K 10-Q · filed 2026-05-11 | |
| 2025-06-30 | -$7.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$10.42M 10-Q · filed 2026-08-10 |
| 2025-03-31 | -$3.05M 10-Q · filed 2026-05-11 |